We are live on ! Find out more
ARMP icon

Armata Pharmaceuticals
ARMP

19 hedge funds and large institutions have $7.84M invested in Armata Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

27% more funds holding

Funds holding: 15 → 19 (+4)

12% less capital invested

Capital invested by funds: $8.89M → $7.84M (-$1.04M)

Holders
19
Holders Change
+4
Holders Change %
+26.67%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$1.19M
2
BGA
Belmont Global Advisors
Texas
+$171K
3
IA
IFP Advisors
Florida
+$86.1K
4
PA
Perceptive Advisors
New York
+$19K
5
MLM
Mount Lucas Management
Pennsylvania
+$9.74K

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$2.2M
2
MP
MSD Partners
New York
-$193K
3
Morgan Stanley
Morgan Stanley
New York
-$14.9K
4
TRCT
Tower Research Capital (TRC)
New York
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
TS
1
Third Security
Virginia
$4.57M – – –
Goldman Sachs
2
Goldman Sachs
New York
$1.28M +$1.19M +2,316 New
MP
3
MSD Partners
New York
$591K -$193K -377 -26%
BGA
4
Belmont Global Advisors
Texas
$492K +$171K +334 +60%
PA
5
Perceptive Advisors
New York
$315K +$19K +37 +7%
Vanguard Group
6
Vanguard Group
Pennsylvania
$275K +$3.08K +6 +1%
RCM
7
RA Capital Management
Massachusetts
$211K – – –
Janney Montgomery Scott
8
Janney Montgomery Scott
Pennsylvania
$64K – – –
MLM
9
Mount Lucas Management
Pennsylvania
$11K +$9.74K +19 New
Deutsche Bank
10
Deutsche Bank
Germany
$10K +$1.02K +2 +12%
Morgan Stanley
11
Morgan Stanley
New York
$9K -$14.9K -29 -64%
IA
12
IFP Advisors
Florida
$7K +$86.1K +168 New
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
$4K +$3.59K +7 New
TJHA
14
Thomas J. Herzfeld Advisors
Florida
$4K +$3.59K +7 New
LTFS
15
Ladenburg Thalmann Financial Services
Florida
$3K – – –
BFA
16
BlackRock Fund Advisors
California
$3K +$513 +1 +25%
Walleye Trading
17
Walleye Trading
New York
$1K +$1.54K +3 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$69 – – –
BC
19
Broadfin Capital
New York
– -$2.2M -3,943 Closed
TRCT
20
Tower Research Capital (TRC)
New York
– -$2K -3 Closed
Creative Planning
21
Creative Planning
Kansas
– +$513 +1 New

ARMP Hedge Fund Activity: Q1 2016 in Review

19 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q1 2016, worth a combined $7.84M — down 12% from $8.89M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new ARMP positions and 3 closed out — a net gain of 4 holders — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Goldman Sachs, opening a new position worth an estimated $1.19M. The largest seller was Broadfin Capital, exiting entirely with an estimated $2.2M sold.

  • 19 institutional investors held Armata Pharmaceuticals (ARMP) as of Q1 2016, up from 15 in Q4 2015.
  • Funds reported $7.84M of Armata Pharmaceuticals stock for Q1 2016, down 12% quarter-over-quarter.
  • 7 funds opened new Armata Pharmaceuticals positions in Q1 2016 and 3 closed out, a net change of +4 holders.
  • The largest Armata Pharmaceuticals buyer in Q1 2016 was Goldman Sachs, an estimated $1.19M added.
  • The largest Armata Pharmaceuticals seller in Q1 2016 was Broadfin Capital, an estimated $2.2M sold.

Based on aggregated 13F filings for Q1 2016.